MS News That Caught My Eye Last Week: Kesimpta, Ocrevus and Chickenpox, Generic Tecfidera, UTIs

Columnist Ed Tobias discusses the week's top MS news, including FDA approval of Kesimpta (ofatumumab), a self-administered treatment.